West Announces First-Quarter 2017 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
UPDATE: West Pharma (WST) Q1 EPS Tops Views; Reaffirms Guidance
April 27, 2017 7:03 AM EDT(Updated - April 27, 2017 9:16 AM EDT)
(Update corrects Q1 EPS)
West Pharma (NYSE: WST) reported Q1 EPS of $0.81, better than the analyst estimate of $0.55. First-quarter 2017 reported-diluted EPS includes the impact of a tax benefit of $0.21. Revenue for the quarter came in at $387.7 million... More
